ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Cannabidiol inhibits invasion and metastasis in colorectal cancer cells by reversing epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway

Feng, PanFeng; Zhu, LongXun; Jie, Jing; Yang, PengXiang; Sheng, Nan; Chen, XiangFan*; Chen, Xia南通大学; 哈尔滨医科大学
Journal of Cancer Research and Clinical Oncology2023-7DOI: 10.1007/s00432-022-04265-x
8被引11阅读
引用收藏
分享

摘要

Colorectal cancer (CRC) is the leading cause of cancer deaths worldwide, wherein distant metastasis is the main reason for death. The non-psychoactive phytocannabinoid cannabidiol (CBD) effectively induces the apoptosis of CRC cells. We investigated the role of CBD in the migration and metastasis of CRC cells. CBD significantly inhibited proliferation, migration, and invasion of colon cancer cells in a dose- or time-dependent manner. CBD could also inhibit epithelial-mesenchymal transition (EMT) by upregulating epithelial markers such as E-cadherin and downregulating mesenchymal markers such as N-cadherin, Snail, Vimentin, and HIF-1 alpha. CBD could suppress the activation of the Wnt/beta-catenin signaling pathway, inhibit the expression of beta-catenin target genes such as APC and CK1, and increase the expression of Axin1. Compared to the control group, the volume and weight of orthotopic xenograft tumors significantly decreased after the CBD treatment. The results demonstrated that CBD inhibits invasion and metastasis in CRC cells. This was the first study elucidating the underlying molecular mechanism of CBD in inhibiting EMT and metastasis via the Wnt/beta-catenin signaling pathway in CRC cells. The molecular mechanism by which CBD inhibits EMT and metastasis of CRC cells was shown to be through the Wnt/beta-catenin signaling pathway for the first time.

学科与关键词

关键词
CannabidiolColorectal cancerEpithelial-mesenchymal transitionWnt/beta-catenin signaling pathwayMetastasis
相关
加载中…
  • Evacetrapib Elicits Antitumor Effects on Colorectal Cancer by Inhibiting the Wnt/β-Catenin Signaling Pathway and Activating the JNK Signaling Pathway
    Hu, Limei; Dong, Haiyan; He, Lingyuan; Shi, Mengchen; Xiang, Nanlin; Su, Yixi; Wang, Chen; Tian, Yu; Hu, Yijia; Wang, Huihui; Liu, Huanliang; Wen, Chuangyu*; Yang, Xiangling*Biological and Pharmaceutical Bulletin, 2022, 45(9): 1238-1245.被引 1
  • Cannabidiol promotes apoptosis of osteosarcoma cells in vitro and in vivo by activating the SP1-CBX2 axis
    Xu, Fangxing; Sun, Guiyuan; Peng, Zhibin; Liu, Jingsong; Li, Zecheng; Yan, Jinglong*American Journal of Translational Research, 2022, 14(2): 1188-1203.被引 2
  • Berberine inhibits tumour growth in vivo and in vitro through suppressing the lincROR-Wnt/β-catenin regulatory axis in colorectal cancer
    Li, Shi-ying; Shi, Chuan-jian; Fu, Wei-ming; Zhang, Jin-fang*Journal of Pharmacy and Pharmacology, 2023, 75(1): 129-138.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Cancer Research and Clinical Oncology
发表日期
2023-07
卷期
第 149 卷, 第 7 期
页码
3587-3598
DOI
10.1007/s00432-022-04265-x
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [31900987]

作者

  • F

    Feng, PanFeng (第一作者)

    2 · nantong univ

  • Z

    Zhu, LongXun

    2 · nantong univ

查看全部 7 位作者收起作者
  • J

    Jie, Jing

    2 · nantong univ

  • Y

    Yang, PengXiang

    nantong univ · harbin med univ

  • S

    Sheng, Nan

    2 · nantong univ

  • C

    Chen, XiangFan (通讯)

    2 · nantong univ

  • C

    Chen, Xia

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417